HDAC inhibitors
and decitabine are highly synergistic
and associated with unique gene-expression
and epigenetic profiles in models of DLBCL.
Kalac M, Scotto L, Marchi E, Amengual J, Seshan VE, Bhagat G, Ulahannan N, Leshchenko VV, Temkin AM, Parekh S, et al. Blood. 2011 Nov 17; 118(20):5506-16. Epub 2011 Jul 19.